News

Check all IrsiCaixa scientific news in just one click.

Visita President Parlament

19/03/2025

President of the Parliament Josep Rull visits IrsiCaixa and the Fight Infections Foundation to support their research

Vaccine HTI

HIV

Vaccines

06/03/2025

Phase II clinical trial AELIX-003 confirms that the immune response to the HTI therapeutic vaccine helps improve HIV control without treatment

Achievement

04/03/2025

30 years of IrsiCaixa: the legacy of past pandemics to face those of the future

Plitidepsina

Emerging pathogens

07/02/2025

Discovering the molecular footprint of a drug: how an anticancer drug can become a solution against multiple viruses

HIV

29/01/2025

Interruption of HIV treatment: a new study guides the design of future clinical trials for an HIV cure

Irene Gonzalez LoViReT

HIV

29/11/2024

The viral reservoir, the main obstacle to eradicating HIV, is up to four times smaller in those who started treatment after 2007

Campus Can Ruti

26/11/2024

Can Ruti Campus remains a globally significant scientific centre due to its medical and research staff

Vaccines

Innovation

25/11/2024

Gilead Sciences acquires investigational assets for the HIV vaccine designed at IrsiCaixa and driven by AELIX Therapeutics

Bebe

HIV

17/10/2024

A low-activity virus sensitive to the immune system: the case of 5 children who keep HIV controlled without antiretroviral treatment